vs
Side-by-side financial comparison of KEMPER Corp (KMPR) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.3× KEMPER Corp). KEMPER Corp runs the higher net margin — -0.7% vs -13.6%, a 12.9% gap on every dollar of revenue. On growth, KEMPER Corp posted the faster year-over-year revenue change (-4.7% vs -5.3%). KEMPER Corp produced more free cash flow last quarter ($166.2M vs $96.0M). Over the past eight quarters, KEMPER Corp's revenue compounded faster (-0.5% CAGR vs -3.6%).
Kemper Corporation is an American insurance provider with corporate headquarters located in Chicago, Illinois. With nearly $13 billion in assets, the Kemper family of companies provides insurance to individuals, families, and businesses.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
KMPR vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $-8.0M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | — | -9.8% |
| Net Margin | -0.7% | -13.6% |
| Revenue YoY | -4.7% | -5.3% |
| Net Profit YoY | -108.2% | -288.1% |
| EPS (diluted) | $-0.03 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.1B | $1.6B |
| Q4 25 | $-8.0M | $-205.0M | ||
| Q3 25 | $-21.0M | $160.0M | ||
| Q2 25 | $72.6M | $145.0M | ||
| Q1 25 | $99.7M | $87.0M | ||
| Q4 24 | $97.4M | $109.0M | ||
| Q3 24 | $73.7M | $359.0M | ||
| Q2 24 | $75.4M | $195.0M | ||
| Q1 24 | $71.3M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | — | -9.8% | ||
| Q3 25 | — | 15.2% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | 11.2% | 13.1% | ||
| Q2 24 | 10.1% | 14.6% | ||
| Q1 24 | 7.6% | 14.5% |
| Q4 25 | -0.7% | -13.6% | ||
| Q3 25 | -1.7% | 10.0% | ||
| Q2 25 | 5.9% | 9.1% | ||
| Q1 25 | 8.4% | 5.8% | ||
| Q4 24 | 8.2% | 6.8% | ||
| Q3 24 | 6.3% | 22.7% | ||
| Q2 24 | 6.7% | 12.1% | ||
| Q1 24 | 6.2% | 12.4% |
| Q4 25 | $-0.03 | $-0.78 | ||
| Q3 25 | $-0.34 | $0.61 | ||
| Q2 25 | $1.12 | $0.56 | ||
| Q1 25 | $1.54 | $0.33 | ||
| Q4 24 | $1.51 | $0.42 | ||
| Q3 24 | $1.14 | $1.38 | ||
| Q2 24 | $1.16 | $0.75 | ||
| Q1 24 | $1.10 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | $943.5M | $8.6B |
| Stockholders' EquityBook value | $2.7B | $752.0M |
| Total Assets | $12.5B | $12.9B |
| Debt / EquityLower = less leverage | 0.35× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | $371.2M | $672.0M | ||
| Q2 25 | $407.6M | $599.0M | ||
| Q1 25 | $545.3M | $547.0M | ||
| Q4 24 | $1.0B | $675.0M | ||
| Q3 24 | $696.9M | $763.0M | ||
| Q2 24 | $539.1M | $704.0M | ||
| Q1 24 | $520.7M | $575.0M |
| Q4 25 | $943.5M | $8.6B | ||
| Q3 25 | $943.1M | $8.8B | ||
| Q2 25 | $942.6M | $8.9B | ||
| Q1 25 | $942.1M | $9.0B | ||
| Q4 24 | $1.4B | $8.9B | ||
| Q3 24 | $1.4B | $8.7B | ||
| Q2 24 | $1.4B | $8.7B | ||
| Q1 24 | $1.4B | $8.7B |
| Q4 25 | $2.7B | $752.0M | ||
| Q3 25 | $2.7B | $906.0M | ||
| Q2 25 | $370.0M | $733.0M | ||
| Q1 25 | $366.0M | $542.0M | ||
| Q4 24 | $2.8B | $472.0M | ||
| Q3 24 | $2.8B | $493.0M | ||
| Q2 24 | $358.0M | $144.0M | ||
| Q1 24 | $2.6B | $48.0M |
| Q4 25 | $12.5B | $12.9B | ||
| Q3 25 | $12.4B | $13.6B | ||
| Q2 25 | $12.6B | $13.5B | ||
| Q1 25 | $12.5B | $13.2B | ||
| Q4 24 | $12.6B | $13.1B | ||
| Q3 24 | $12.6B | $12.8B | ||
| Q2 24 | $12.6B | $12.2B | ||
| Q1 24 | $12.6B | $11.9B |
| Q4 25 | 0.35× | 11.49× | ||
| Q3 25 | 0.35× | 9.74× | ||
| Q2 25 | 2.55× | 12.14× | ||
| Q1 25 | 2.57× | 16.52× | ||
| Q4 24 | 0.50× | 18.81× | ||
| Q3 24 | 0.50× | 17.75× | ||
| Q2 24 | 3.88× | 60.11× | ||
| Q1 24 | 0.54× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.0M | $141.0M |
| Free Cash FlowOCF − Capex | $166.2M | $96.0M |
| FCF MarginFCF / Revenue | 14.7% | 6.4% |
| Capex IntensityCapex / Revenue | 0.8% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $553.9M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.0M | $141.0M | ||
| Q3 25 | $139.9M | $264.0M | ||
| Q2 25 | $89.6M | $220.0M | ||
| Q1 25 | $180.0M | $75.0M | ||
| Q4 24 | $175.1M | $390.0M | ||
| Q3 24 | $141.9M | $141.0M | ||
| Q2 24 | $22.9M | $332.0M | ||
| Q1 24 | $43.0M | $76.0M |
| Q4 25 | $166.2M | $96.0M | ||
| Q3 25 | $133.4M | $218.0M | ||
| Q2 25 | $82.0M | $181.0M | ||
| Q1 25 | $172.3M | $43.0M | ||
| Q4 24 | $165.4M | $335.0M | ||
| Q3 24 | $131.4M | $99.0M | ||
| Q2 24 | $5.2M | $300.0M | ||
| Q1 24 | $27.7M | $30.0M |
| Q4 25 | 14.7% | 6.4% | ||
| Q3 25 | 10.8% | 13.6% | ||
| Q2 25 | 6.7% | 11.4% | ||
| Q1 25 | 14.4% | 2.8% | ||
| Q4 24 | 13.9% | 21.0% | ||
| Q3 24 | 11.1% | 6.3% | ||
| Q2 24 | 0.5% | 18.7% | ||
| Q1 24 | 2.4% | 1.8% |
| Q4 25 | 0.8% | 3.0% | ||
| Q3 25 | 0.5% | 2.9% | ||
| Q2 25 | 0.6% | 2.4% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 0.8% | 3.5% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 1.6% | 2.0% | ||
| Q1 24 | 1.3% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | 1.23× | 1.52× | ||
| Q1 25 | 1.81× | 0.86× | ||
| Q4 24 | 1.80× | 3.58× | ||
| Q3 24 | 1.93× | 0.39× | ||
| Q2 24 | 0.30× | 1.70× | ||
| Q1 24 | 0.60× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KMPR
| Specialty Property Casualty Insurance Segment | $995.1M | 88% |
| Life Insurance Segment1 | $140.7M | 12% |
OGN
Segment breakdown not available.
